skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Addendum for '06 report: FY05 LDRD-ER, FY06 Report, Rapid Defense Against the Next-Generation Biothreat

Technical Report ·
DOI:https://doi.org/10.2172/1016926· OSTI ID:1016926

Prior to using human nasopharyngeal samples, we will use prepared mixtures of viruses with bacteria and eukaryotic cells in our research on microfluidic separation techniques. Some examples of these mixtures are the bacteriophage MS2 with its host bacteria, E. coli, and BSL-1, Risk-Group-1 virus such as fowlpox virus vaccine with its host cell, DF-1, derived from chickens.

Research Organization:
Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
W-7405-ENG-48
OSTI ID:
1016926
Report Number(s):
UCRL-TR-227807; TRN: US201113%%356
Country of Publication:
United States
Language:
English